"Most troubling is that some GPOs are funded by suppliers rather than solely by hospitals. The fees that suppliers pay, which would normally be considered illegal kickbacks, are allowed by the 1986 amendment to the Social Security Act. Thus, buying groups may serve the interests of the suppliers that provide their funding, not providers, thereby undermining value-based competition. While the extent of this bias is contested, the potential for conflict of interest is indisputable."
"To enable value-based competition, every buying-group practice should be consistent with open and fair competition. There is no valid reason for buying groups to accept financing or any payments from suppliers: if a buying group adds value, the customers (hospitals) should voluntarily pay for it."
Michael E. Porter, professor, Harvard Business School, & Elizabeth Olmsted Teisberg, professor, Dartmouth Center for Health Care Delivery Science"
"Porter & Teisberg, "Redefining Health Care," Harvard Business School Press, 2006
* * * * *
"An American Sickness: How Healthcare Became Big Business And How You Can Take It Back"
Elisabeth Rosenthal M.D.,
Penguin Press, New York 2017
"Drug Shortages: An exploration of the relationship between U.S. market forces and sterile injectable pharmaceutical products: Interviews with 10 pharmaceutical companies"
Pew Charitable Trusts
"Premier Inc. [PINC] Accounting Analysis"
Sohn Investment Conference
Cavendish Fund Management
May 4, 2015
"Medicines Shortages in European Hospitals"
European Journal of Hospital Pharmacy
"Outbreak of Serratia marcescens Bloodstream Infections in Patients Receiving Parenteral Nutrition Prepared by a Compounding Pharmacy"
Clinical Infectious Diseases, Aug. 24, 2014
"Report of the 2014 Drug Shortages Summit"
Aug. 1, 2014 (date of meeting)
"Drug Shortages: Crisis and Opportunity"
Pharma Ci USA Conference
Sept. 17, 2013
"Report of the 2013 Drug Shortages Summit: Evaluating Long-Term Solutions"
Apr. 18, 2013 (date of meeting)
"Economic and Technological Drivers of Generic Sterile Injectable Drug Shortages"
Journal of Clinical Pharmacology and Therapeutics
"Revisiting Supply Cost Strategies"
Advisory Board Company, 2013
Rosemary Gibson & Janardan Prasad Singh
Rowman & Littlefield Publishers, New York, 2013
"Healthcare Intermediaries: Competition and Healthcare Policy at Loggerheads?"
Diana Moss PhD, American Antitrust Institute
May 7, 2012
"Report 7 of the Council on Science and Public Health: Drug Shortage Update"
American Medical Association
"Connecting the Dots: How Anticompetitive Contracting Practices, Kickbacks, and Self-dealing by Hospital Group Purchasing Organizations (GPOs) Caused the U. S. Drug Shortage"
Patricia Earl, principal/CEO Secure Pharma Distributors Network & Phillip L. Zweig,
financial journalist, author & independent consultant
Jan. 4, 2012
"Drug Shortages: A closer look at suppliers, products, and volume volatility"
IMS Institute for Healthcare Infomatics
"An Empirical Analysis of Aftermarket Transactions by Hospitals"
Journal of Contemporary Health Law & Policy, Fall 2011
"Report 2 of the Council on Science and Public Health: National Drug Shortages"
American Medical Association
"Drug Shortage Summit Summary Report"
American Society of Health-System Pharmacists
Nov. 5, 2010
"Group Purchasing Organizations: An Undisclosed Scandal in the U. S. Healthcare Industry"
Prof. S. Prakash Sethi
"Group Purchasing Organizations' Distributor Fees Formula Requires Scrutiny: Current Practice Fails to Meet New Standards for Transparency, Ethics, and Integrity in GPO Contracting"
Report by the Health Industry Distributors Association (HIDA)
"Redefining Health Care"
Professors Michael Porter & Elizabeth Teisberg
Harvard Business School Press, 2006.
"Group Purchasing Organizations: An Evaluation of their Effectiveness in Providing Services to Hospitals and their Patients"
Prof. S. Prakash Sethi, Center for Corporate Accountability, Baruch College, City University of New York
July 20, 2006
"Defining and Measuring Product-Based Cost Savings in the Health Care Supply Chain"
Lynn James Everard, healthcare supply chain strategist
"The Impact of Group Purchasing on the Financial Prospects of Health Systems: Changing Value Perceptions and Unintended Consequences"
Lynn James Everard, V.I.P.E.R Group Inc.
"Is America's Health Care Hindered by Group Purchasing Organizations?"
Garret G. Rasmussen, Washington Legal Foundation
Apr. 26, 2002